Vycor Medical (VYCO) Non Operating Income (2010 - 2026)
Vycor Medical's (VYCO) quarterly Non Operating Income came in at -$25960.0 in Q2 2026, down 2.07% year-over-year from -$26509.3 in Q2 2025, and down 0.96% quarter-over-quarter from -$25713.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Non Operating Income (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Non Operating Income for 17 consecutive years, with -$25960.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Income fell 2.07% year-over-year to -$25960.0 in Q2 2026; TTM through Jun 2026 was -$104622.0, a 2.77% decrease from a year earlier, with the FY2025 full-year figure at -$104090.0, down 6.42% from the prior year.
- Non Operating Income was -$25960.0 for Q2 2026 at Vycor Medical, down from -$25713.0 in the prior quarter.
- Over five years, Non Operating Income peaked at -$20898.0 in Q1 2022 and troughed at -$27095.0 in Q3 2025.
- A 5-year average of -$25001.7 and a median of -$25710.5 in 2025 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income plunged 125.26% in 2022 and climbed 18.19% in 2024, its largest moves.
- Over 5 years, Non Operating Income stood at -$24674.0 in 2022, then dropped by 4.99% to -$25905.0 in 2023, then fell by 0.48% to -$26029.0 in 2024, then gained by 0.67% to -$25854.0 in 2025, then fell by 0.41% to -$25960.0 in 2026.
- The last three Non Operating Income figures came in at -$25960.0 (Q2 2026), -$25713.0 (Q1 2026), and -$25854.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -25,960.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25,960.00 |
| Mar 31, 2026 | -25,713.00 |
| Dec 31, 2025 | -25,854.00 |
| Sep 30, 2025 | -27,095.00 |
| Jun 30, 2025 | -25,433.00 |
| Mar 31, 2025 | -25,708.00 |
| Dec 31, 2024 | -26,029.00 |
| Sep 30, 2024 | -24,635.00 |
| Jun 30, 2024 | -26,167.00 |
| Mar 31, 2024 | -20,975.00 |
| Dec 31, 2023 | -25,905.00 |
| Sep 30, 2023 | -25,998.00 |
| Jun 30, 2023 | -25,729.00 |
| Mar 31, 2023 | -25,639.00 |
| Dec 31, 2022 | -24,674.00 |
| Sep 30, 2022 | -24,267.00 |
| Jun 30, 2022 | -23,352.00 |
| Mar 31, 2022 | -20,898.00 |
| Dec 31, 2021 | -21,906.00 |
| Sep 30, 2021 | 96,055.00 |